184 related articles for article (PubMed ID: 21624116)
1. The synthetic peptide P111-136 derived from the C-terminal domain of heparin affin regulatory peptide inhibits tumour growth of prostate cancer PC-3 cells.
Hamma-Kourbali Y; Bermek O; Bernard-Pierrot I; Karaky R; Martel-Renoir D; Frechault S; Courty J; Delbé J
BMC Cancer; 2011 May; 11():212. PubMed ID: 21624116
[TBL] [Abstract][Full Text] [Related]
2. Dominant negative effectors of heparin affin regulatory peptide (HARP) angiogenic and transforming activities.
Bernard-Pierrot I; Delbé J; Rouet V; Vigny M; Kerros ME; Caruelle D; Raulais D; Barritault D; Courty J; Milhiet PE
J Biol Chem; 2002 Aug; 277(35):32071-7. PubMed ID: 12070152
[TBL] [Abstract][Full Text] [Related]
3. Heparin affin regulatory peptide binds to vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis.
Héroult M; Bernard-Pierrot I; Delbé J; Hamma-Kourbali Y; Katsoris P; Barritault D; Papadimitriou E; Plouet J; Courty J
Oncogene; 2004 Mar; 23(9):1745-53. PubMed ID: 15001987
[TBL] [Abstract][Full Text] [Related]
4. Heparin affin regulatory peptide/pleiotrophin negatively affects diverse biological activities in C6 glioma cells.
Parthymou A; Lampropoulou E; Mikelis C; Drosou G; Papadimitriou E
Eur J Cell Biol; 2008 Jan; 87(1):17-29. PubMed ID: 17881084
[TBL] [Abstract][Full Text] [Related]
5. A basic peptide derived from the HARP C-terminus inhibits anchorage-independent growth of DU145 prostate cancer cells.
Bermek O; Diamantopoulou Z; Polykratis A; Dos Santos C; Hamma-Kourbali Y; Burlina F; Delbé J; Chassaing G; Fernig DG; Katsoris P; Courty J
Exp Cell Res; 2007 Nov; 313(19):4041-50. PubMed ID: 17727841
[TBL] [Abstract][Full Text] [Related]
6. A Pleiotrophin C-terminus peptide induces anti-cancer effects through RPTPβ/ζ.
Diamantopoulou Z; Bermek O; Polykratis A; Hamma-Kourbali Y; Delbé J; Courty J; Katsoris P
Mol Cancer; 2010 Aug; 9():224. PubMed ID: 20738847
[TBL] [Abstract][Full Text] [Related]
7. Characterization of heparin affin regulatory peptide signaling in human endothelial cells.
Polykratis A; Katsoris P; Courty J; Papadimitriou E
J Biol Chem; 2005 Jun; 280(23):22454-61. PubMed ID: 15797857
[TBL] [Abstract][Full Text] [Related]
8. Proliferation and migration activities of fibroblast growth factor-2 in endothelial cells are modulated by its direct interaction with heparin affin regulatory peptide.
Dos Santos C; Blanc C; Elahouel R; Prescott M; Carpentier G; Ori A; Courty J; Hamma-Kourbali Y; Fernig DG; Delbé J
Biochimie; 2014 Dec; 107 Pt B():350-7. PubMed ID: 25315978
[TBL] [Abstract][Full Text] [Related]
9. Heparin affin regulatory peptide is a key player in prostate cancer cell growth and angiogenicity.
Hatziapostolou M; Delbe J; Katsoris P; Polytarchou C; Courty J; Papadimitriou E
Prostate; 2005 Oct; 65(2):151-8. PubMed ID: 15924335
[TBL] [Abstract][Full Text] [Related]
10. Mitogenic and in vitro angiogenic activity of human recombinant heparin affin regulatory peptide.
Laaroubi K; Delbé J; Vacherot F; Desgranges P; Tardieu M; Jaye M; Barritault D; Courty J
Growth Factors; 1994; 10(2):89-98. PubMed ID: 7520717
[TBL] [Abstract][Full Text] [Related]
11. Identification of heparin affin regulatory peptide domains with potential role on angiogenesis.
Polykratis A; Delbé J; Courty J; Papadimitriou E; Katsoris P
Int J Biochem Cell Biol; 2004 Oct; 36(10):1954-66. PubMed ID: 15203110
[TBL] [Abstract][Full Text] [Related]
12. Involvement of heparin affin regulatory peptide in human prostate cancer.
Vacherot F; Caruelle D; Chopin D; Gil-Diez S; Barritault D; Caruelle JP; Courty J
Prostate; 1999 Feb; 38(2):126-36. PubMed ID: 9973098
[TBL] [Abstract][Full Text] [Related]
13. Antitumorigenic effects of a mutant of the heparin affin regulatory peptide on the U87 MG glioblastoma cell line.
Dos Santos C; Karaky R; Renoir D; Hamma-Kourbali Y; Albanese P; Gobbo E; Griscelli F; Opolon P; Dalle S; Perricaudet M; Courty J; Delbé J
Int J Cancer; 2010 Sep; 127(5):1038-51. PubMed ID: 20013808
[TBL] [Abstract][Full Text] [Related]
14. Effect of heparin on bovine epithelial lens cell proliferation induced by heparin affin regulatory peptide.
Delbé J; Vacherot F; Laaroubi K; Barritault D; Courty J
J Cell Physiol; 1995 Jul; 164(1):47-54. PubMed ID: 7790396
[TBL] [Abstract][Full Text] [Related]
15. The lysine-rich C-terminal tail of heparin affin regulatory peptide is required for mitogenic and tumor formation activities.
Bernard-Pierrot I; Delbe J; Caruelle D; Barritault D; Courty J; Milhiet PE
J Biol Chem; 2001 Apr; 276(15):12228-34. PubMed ID: 11150308
[TBL] [Abstract][Full Text] [Related]
16. A peptide corresponding to the C-terminal region of pleiotrophin inhibits angiogenesis in vivo and in vitro.
Mikelis C; Lamprou M; Koutsioumpa M; Koutsioubas AG; Spyranti Z; Zompra AA; Spiliopoulos N; Vradis AA; Katsoris P; Spyroulias GA; Cordopatis P; Courty J; Papadimitriou E
J Cell Biochem; 2011 Jun; 112(6):1532-43. PubMed ID: 21344482
[TBL] [Abstract][Full Text] [Related]
17. HARP induces angiogenesis in vivo and in vitro: implication of N or C terminal peptides.
Papadimitriou E; Polykratis A; Courty J; Koolwijk P; Heroult M; Katsoris P
Biochem Biophys Res Commun; 2001 Mar; 282(1):306-13. PubMed ID: 11264008
[TBL] [Abstract][Full Text] [Related]
18. Terrestrosin D, a steroidal saponin from Tribulus terrestris L., inhibits growth and angiogenesis of human prostate cancer in vitro and in vivo.
Wei S; Fukuhara H; Chen G; Kawada C; Kurabayashi A; Furihata M; Inoue K; Shuin T
Pathobiology; 2014; 81(3):123-32. PubMed ID: 24642631
[TBL] [Abstract][Full Text] [Related]
19. The angiogenic factor heparin affin regulatory peptide (HARP) induces proliferation of human peripheral blood mononuclear cells.
Achour A; Laaroubi D; Caruelle D; Barritault D; Courty J
Cell Mol Biol (Noisy-le-grand); 2001; 47 Online Pub():OL73-7. PubMed ID: 11936877
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of the mitogenic, angiogenic and tumorigenic activities of pleiotrophin by a synthetic peptide corresponding to its C-thrombospondin repeat-I domain.
Hamma-Kourbali Y; Bernard-Pierrot I; Heroult M; Dalle S; Caruelle D; Milhiet PE; Fernig DG; Delbé J; Courty J
J Cell Physiol; 2008 Jan; 214(1):250-9. PubMed ID: 17607711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
